Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing
Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges
AIDS 2026 webinar: highlights from Rio de Janeiro
AIDS 2026 news coming soon
Experts publish recommendations on managing low-level but detectable HIV
From ‘life span’ to ‘health span’ – new guidelines for ageing with HIV in South Africa
Modelling study backs targeted, not universal, lenacapavir PrEP for pregnancy and breastfeeding
Kaposi sarcoma claims lives of South Africans with HIV, despite the ART rollout
Worse HIV control at diagnosis doesn't mean worse lymphoma outcomes
